| Completed | A Randomized, Double Masked, Parallel Group, Dose-finding Study to Evaluate SYL1801 in Patients With Neovascul Wet Macular Degeneration, Neovascular Age-related Macular Degeneration, Macular Degeneration | Phase 2 | 2022-11-22 |
| Completed | Safety Study of Tivanisiran to Treat Dry Eye Dry Eye Disease | Phase 3 | 2022-03-24 |
| Completed | Tivanisiran for Dry Eye in Subjects With Sjögren's Syndrome Dry Eye Disease, Sjögren Syndrome | Phase 3 | 2021-05-25 |
| Completed | Safety, Tolerability and Pharmacokinetic Profile of SYL1801 Eye Drops Safety, Tolerability and Pharmacokinetic Profile in Healthy Volunteers, Choroidal Neovascularization | Phase 1 | 2021-03-17 |
| Completed | HELIX, a Double-masked Study of SYL1001 in Patients With Moderate to Severe Dry Eye Disease (DED) Dry Eye Disease | Phase 3 | 2017-05-18 |
| Completed | Dose-finding Study to Assess the Safety and Effect of SYL1001 in Patients With Ocular Pain Ocular Pain, Dry Eye Syndrome | Phase 2 | 2015-06-01 |
| Completed | SYL040012, Treatment for Open Angle Glaucoma Open Angle Glaucoma, Ocular Hypertension | Phase 2 | 2014-10-01 |
| Completed | Pilot Study to Evaluate SYL1001 Safety and Effect in Patients With Ocular Pain Ocular Pain, Dry Eye Syndrome | Phase 1 / Phase 2 | 2012-11-01 |
| Completed | Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Ocular Hypertension, Open Angle Glaucoma | Phase 2 | 2012-07-01 |
| Completed | Study to Evaluate the Ocular Tolerance of SYL1001 in Healthy Volunteers Ocular Pain, Dry Eye | Phase 1 | 2011-07-01 |
| Completed | SYL040012. Tolerance and Effect on Intraocular Pressure in Subjects With Intraocular Pressure (IOP) >= 21 mm H Glaucoma, Ocular Hypertension | Phase 1 / Phase 2 | 2010-10-01 |
| Completed | Tolerance and Effect on Intraocular Pressure After Administration of SYL040012 Ocular Hypertension, Glaucoma | Phase 1 | 2009-09-01 |